Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2001
10/16/2001US6303342 Recombinant methods and materials for producing epothilones C and D
10/16/2001US6302958 Sonic impinging jet crystallization apparatus and process
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074898A2 Charged compounds comprising a nucleic acid binding moiety and uses therefor
10/11/2001WO2001074820A1 Novel derivatives and analogues of galanthamin
10/11/2001WO2001074812A1 Novel benzosultam oxazolidinone antibacterial agents
10/11/2001WO2001074811A2 Substituted 1,3-thiazole compounds, their production and use
10/11/2001WO2001074804A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
10/11/2001WO2001074793A2 Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1
10/11/2001WO2001074788A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001WO2001074774A1 Ethylenediamine derivatives
10/11/2001WO2001074771A1 Pyrrole-2,5-dione derivatives for the treatment of diabetes
10/11/2001WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001WO2001074344A2 Small organic molecule regulators of cell proliferation
10/11/2001WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001WO2001002377A9 Telomerase inhibitors and methods of their use
10/11/2001WO2000016763A3 Antimalarial agents
10/11/2001US20010029263 Alopecia
10/11/2001US20010029261 Alopecia therapy
10/11/2001DE10015836A1 New epothilone derivatives used for treating e.g. malignant melanoma, breast carcinoma, psoriasis, multiple sclerosis and arthritis
10/11/2001CA2405144A1 Ethylenediamine derivatives
10/11/2001CA2405132A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001CA2404413A1 Small organic molecule regulators of cell proliferation
10/11/2001CA2404386A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2404384A1 Substituted 1,3-thiazole compounds, their production and use
10/11/2001CA2403537A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor
10/11/2001CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001CA2399275A1 Novel benzosultam oxazolidinone antibacterial agents
10/11/2001CA2368966A1 New derivatives and analogues of galanthamine
10/10/2001EP1142885A1 Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives
10/10/2001EP1142882A1 Acrylonitrile compounds
10/10/2001EP1140944A1 Epothilone derivatives and their use as antitumor agents
10/10/2001EP1140927A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140921A1 4-trifluoromethyl-3-oxazolylpyridines, method for producing them, products containing the same, and their use as pesticides
10/10/2001EP1140918A1 Thrombin inhibitors
10/10/2001EP1140917A1 S-oxide lipid lowering compounds
10/10/2001EP1140915A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
10/10/2001EP1140913A1 Thiourea inhibitors of herpes viruses
10/10/2001EP1140909A1 Novel inhibitors of farnesyl-protein transferase
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140905A1 Heteroaromatic amides as inhibitor of factor xa
10/10/2001EP1140904A1 Farnesyl protein transferase inhibitors
10/10/2001EP1140903A1 Aromatic amides
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140846A1 Aspartic protease inhibitors
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140834A1 Heterocyclic piperidines as modulators of chemokine receptor activity
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140099A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia
10/10/2001EP1140087A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140086A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140081A2 Improving mental performance by increasing brain insulin sensitivity
10/10/2001EP1051170B1 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001CN1317004A Benzoyl derivatives, method for producing them and their use as herbicides and plant growth regulators
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316426A Uracil compound and its appliance
10/10/2001CN1072669C Benzimidazole compounds and their use as modulators of the GABAA receptor complex
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072660C 2,1,3-benzothia (oxa) diazole derivatives having endothelin receptor antagonistic effect
10/10/2001CN1072657C 1,2,3-thiadiazole derivatives and salts thereof, disease controlling agent for agricultural and horiticultural use and method for use thereof
10/10/2001CN1072655C New Heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical composition containing their
10/10/2001CN1072652C Substd benzoylaminothizole derivatives and drugs containing same
10/10/2001CN1072651C Intermediates for preparation of 2-imidzaoline-5-ones
10/09/2001US6300363 Indole compounds as COX-2 inhibitors
10/09/2001US6300355 For therapy of cancer
10/09/2001US6300354 For therapy of neuroleptic diseases
10/09/2001US6300316 C-4 substituted macrolide antibiotics
10/09/2001CA2119662C New nitrogen bicyclic derivatives, their preparation process and pharmaceutical compositions comtaining them
10/09/2001CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators
10/04/2001WO2001072745A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders
10/04/2001WO2001072737A1 Triarylimidazole derivatives as cytokine inhibitors
10/04/2001WO2001072726A1 Oxime derivatives for controlling undesired microorganisms and animal pests
10/04/2001WO2001072725A1 BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072721A2 Synergistic methods and compositions for treating cancer
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027201 Non-systemic control of parasites
10/04/2001US20010027200 PPARgamma modulators
10/04/2001US20010027194 Novel compounds useful as neuro-protective agents
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 628